All Work

Chris Lange

As Valeant Ups Salix Buyout, Will Endo Come Back?

Salix Pharmaceuticals and Valeant Pharmaceuticals have announced that they had entered into an agreement on their plan to merge based on a new price for Salix shares.

Chris Lange · 12 years ago

5 Highly Unusual Stock Moves of the Past Week

Stocks are still very close to all-time highs, and this bull market is now six years old. It turns out that some stocks made unusual moves last week.

Chris Lange · 12 years ago

Par Pharma Files for IPO

Par Pharmaceutical Holdings has filed with the U.S. Securities and Exchange Commission (SEC) for an initial public offering.

Chris Lange · 12 years ago

FXCM Shows It Is a Survivor

FXCM shares rose sharply after it reported better-than-expected fourth-quarter results Thursday after the markets closed.

Chris Lange · 12 years ago

Is Civeo Doomed?

Civeo reported better-than-expected fourth-quarter earnings Thursday after the U.S. markets closed.

Chris Lange · 12 years ago

More All-Time Highs After Ulta Earnings

Thursday after the markets closed, Ulta Salon, Cosmetics & Fragrance released its fourth-quarter and full-year earnings report.

Chris Lange · 12 years ago

The Gamble That Did Not Pay Off

Zogenix has announced an agreement for the sale of its Zohydro ER (hydrocodone bitartrate) business to Pernix for $100 million.

Chris Lange · 12 years ago

Goldman Sachs BDC Files for IPO

Goldman Sachs BDC has announced plans for an initial public offering (IPO) of some 6 million shares.

Chris Lange · 12 years ago